zoetis abaxis fuse

3350807.04. Create a truly revolutionary connection between you, your Abaxis Diagnostic Laboratory and your patients. VETSCAN ® UA Urine Analyzer. For more information, visit http://www.abaxis.com. 3924259.05. In a complex market environment, this growth will allow us to communicate the superior quality and performance of the Abaxis brand to the full benefit of our existing and future customers. We're among the first cloud practice management software companies to … VETSCAN ® FUSE Easy-to-use portable chemistry analyzer. Test chemistry and electrolyte analytes on a single profile. 3369341.09. Copies of the proxy statement and the filings with the SEC that will be incorporated by reference therein can also be obtained, without charge, by directing a request to Abaxis, Inc., 3240 Whipple Road, Union City, CA94587, Attention: Corporate Secretary; telephone (510) 675-6500, or from Abaxis’ website www.abaxis.com. Easy-to-use urine chemistry analyzer. Abaxis is a worldwide developer, manufacturer and marketer of portable blood analysis systems that are used in a broad range of medical specialties in human or veterinary patient care to provide clinicians with rapid blood constituent measurements. 11569807.880000001. 4937861.7500000009. Abaxis Media & Investors: Investors and the public may access the live webcast by visiting the Zoetis website at http://investor.zoetis.com/events-presentations. Abaxis shareholders can find more information about the transaction and the merger consideration by calling Computershare at 1-800-546-5141 (within USA, US territories and Canada) or 1-781-575-2765 … Abaxishas more than 580 employees worldwide. This acquisition gives recognition to our record of success and the highly skilled, dedicated employees of Abaxis who helped build our company over the course of nearly three decades.”. Zoetis announced a definitive merger agreement pursuant to which Zoetis will acquire Abaxis, a leader in the development, manufacture and marketing of diagnostic instruments for veterinary point-of-care services for US $83 per share in cash, or approximately $2.0 billion in aggregate. Combining the best on-site diagnostics at reference laboratory standards, ABAXIS offers a single, comprehensive and trusted partner for all your testing needs. Analyser Case Studies; Members Area; ABAXIS delivers it all. Abaxis, founded in 1989 and headquartered in Union City, Calif., is a leading provider of diagnostic instruments and consumable discs, kits and cartridges to the animal health industry. 3799827.52. Zoetis ist ein weltweit agierendes Tiergesundheitsunternehmen, das sich der Aufgabe widmet, die Herausforderungen seiner Kunden auf immer bessere Weise zu lösen. 12748490.200000001. Die Inhalte dieser Seite sind für Nutzer Deutschland bestimmt. In a complex market environment, this growth will allow us to communicate the superior quality and performance of the Abaxis brand to the full benefit of our existing and future customers. Zoetis Investors: Easy-to-use portable chemistry analyzer. Welcome to our online store. Cautionary Statement Regarding Forward-Looking Information. › VETSCAN FUSE › AlphaTRAK Glucose Meter: 12 Profiles to Choose From. Comprehensive. PARSIPPANY, N.J. and UNION CITY, Calif.--(BUSINESS WIRE)--May 16, 2018-- Zoetis Inc. (NYSE:ZTS) and Abaxis, Inc. (NASDAQ:ABAX) today announced a definitive merger agreement pursuant to which Zoetis will acquire Abaxis, a leader in the development, manufacture and marketing of diagnostic instruments for veterinary point-of-care services for US $83per share in cash, or approximately $2.0 billion in aggregate. Zoetisexpects the transaction to be accretive to the company’s earnings in 2019. FUSE empowers you to have more meaningful conversations with pet owners and builds the value of diagnostics by sharing dramatically enhanced test results on a variety of devices in your practice and beyond. VETSCAN IMAGYST ™ Innovation that transforms diagnostics. Additional factors that could cause results to differ materially from those described above can be found in Zoetis’ Annual Report on Form 10-K for the year ended December 31, 2017, which is on file with the Securities and Exchange Commission (the “SEC”) and in other documents Zoetis files with the SEC, and in Abaxis’ Annual Report on Form 10-K for the year ended March 31, 2017, and Quarterly Report on Form 10-Q for the quarter ended December 31, 2017, which are on file with the SEC and in other documents Abaxis files with the SEC. From there you will see the order on the Fuse Site. Zoetis Inc. and Abaxis Inc. announced a definitive merger agreement pursuant to which Zoetis will acquire Abaxis, a leader in the development, manufacture and marketing of diagnostic instruments for veterinary point-of-care services for $83 per share in cash, or approximately $2.0 billion in aggregate. Combining the best on-site diagnostics at reference laboratory standards, ABAXIS offers a single, comprehensive and trusted partner for all your testing needs. or Analyser Case Studies ; Members Area; ABAXIS delivers it all. Company Name Exchange:Ticker Industry Group Country Broad Group Magna International Inc. (TSX:MG) TSX:MG Auto Parts Canada Australia, NZ and Canada TSX:CTC.A Retail (General) TSX: Zoetis Reference Laboratories. FUSE empowers you to have more meaningful conversations with pet owners and builds the value of diagnostics by sharing dramatically enhanced test results on a variety of devices in your practice and beyond. Information regarding Abaxis’ directors and executive officers is available in Abaxis’ definitive proxy statement, which was filed with the SEC on September 19, 2017, and certain of its Current Reports on Form 8-K. Information regarding Zoetis’ directors is available in Zoetis’ definitive proxy statement, which was filed with the SEC on April 2, 2018, and information regarding Zoetis’ executive officers is available in Zoetis’ Annual Report on Form 10-K for the year ended December 31, 2017, which was filed with the SEC on February 15, 2018. steve.frank@zoetis.com ZOETIS TO ACQUIRE ABAXIS, A LEADING GLOBAL PROVIDER OF VETERINARY POINT-OF-CARE DIAGNOSTIC INSTRUMENTS. The Abaxis VETSCAN portfolio includes chemistry and hematology diagnostic instruments and companion discs, kits and cartridges, which are consumables that create a recurring revenue stream. Abaxis, founded in 1989 and headquartered in Union City, Calif., is a leading provider of diagnostic instruments and consumable discs, kits and cartridges to the animal health industry. The Fuse integration is a Bi-Directional integration that allows your Abaxis/Zoetis devices such as the VS2 and HM5 to receive orders prior to running the actual tests. The veterinary diagnostics category, which includes reference laboratory and point-of-care diagnostics, is estimated to be more than $3 billion1, with compound annual growth of 10% over the past three years1. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products, genetic tests, biodevices and a range of services. Elinore White, 1-973-443-2835 (o) Abaxis, Zoetis and certain of their respective directors, executive officers and employees may be deemed to be participants in the solicitation of proxies in respect of the proposed transaction. Abaxis has a near-term pipeline of products, including an update to the capabilities of its VETSCAN FUSE®, a bi-directional connectivity system that provides integration between Abaxis point-of-care instruments and veterinary practice management systems worldwide. (August 1) — Zoetis announced Tuesday the completion of its acquisition of Abaxis, a developer and manufacturer of diagnostic instruments for veterinary point-of-care services, for nearly $2 billion—$83 per share in cash. Cooley LLP is acting as legal advisor to Abaxis, and Piper Jaffray is acting as its exclusive financial advisor. Before making any voting decision, shareholders of Abaxisare urged to read the proxy statement regarding the transaction when it becomes available and any other relevant documents filed with the SEC, as well as any amendments or supplements to those documents, because they will contain important information about the proposed transaction. Zoetis Inc. completed the acquisition of Abaxis Inc. on July 31, 2018. Acquisition Gives Zoetis a New Platform for Growth, “This acquisition brings Zoetis a company that has a proven, competitive diagnostic platform for growth that we can help to accelerate in the U.S. and worldwide with our global scale and direct customer relationships in approximately 45 countries,” said Juan Ramón Alaix, Chief Executive Officer of Zoetis. Zoetisexpects the diagnostics category to continue to grow faster than the animal health industry, with growth in the mid to high single digits, driven by international adoption of point-of-care diagnostic instruments due to rising medicalization rates, increasing standard of veterinary care and the convenience of in-clinic testing1. How does it work? Abaxis, Inc. ABLZF.PK ABB LTD ZUERICH ABB ABB Ltd. ABBN.VX ABB N VTX ABT Abbott Laboratories ABBV AbbVie Inc. 036010.KQ ABCO Electronics Co., Ltd. ABCE ABCO Energy, Inc. ABI.V Abcourt Mines Inc. ABE.V ABE Resources Inc. ABN.V Aben Resources Ltd. ABNAF AY03.SG ABENGOA OR14-B-ABGB Abengoa SA ABGOF AYO.DE AY3.F ABENGOA YIELD AY3.MU ABY Abengoa Yield plc ANF … Wachtell, Lipton, Rosen & Katz is acting as legal advisor to Zoetis, and Guggenheim Securities and Barclays are acting as financial advisors. Zoetis will provide additional updates as the transaction progresses towards closing. VETSCAN ® SA Sediment Analyzer. Zoetis anticipates the transaction will have an impact on 2018 reported earnings related to customary closing activities; however, on an adjusted basis, the company does not expect a material impact. VETSCAN IMAGYST ™ Innovation that transforms diagnostics. Abaxis’s mission is to improve the efficiency of care delivery to and the quality of life of patients in the medical and veterinary markets. Zoetis will now embark on a new adventure, taking all the motivation and experience from the QCR employees, as we look to develop further with improved operational structure. Abaxis reported revenue of $244.7 million for its fiscal year ended March 31, … Bill Price, 1-973-443-2742 (o) We're delighted to announce our new integration with Zoetis Fuse. Abaxis, Piccolo, Piccolo Xpress are trademarks or registered trademarks of Abaxis, Inc. Our veterinary products can now be viewed at ZoetisUS.com/dx, Zoetis to Acquire Abaxis | Leading Global Provider of Veterinary Point-of-Care Diagnostic Instruments, https://www.businesswire.com/news/home/20180516005611/en/, http://investor.zoetis.com/events-presentations, Purchase price of US $83 per share in cash, or approximately $2.0 billion in aggregate, Enhances Zoetis’ presence in veterinary diagnostics, a category of the animal health industry with approximately 10%compound annual growth over the last three years, Brings to Zoetis a proven line of diagnostic instruments and consumables, providing a new platform for growth that Zoetis can accelerate with sales of its products in more than 100 countries, Further enables Zoetis to support veterinarians with comprehensive solutions to predict, prevent, detect and treat diseases in animals, Affirms strategy to deploy capital in complementary, high-growth segments of animal health industry. Die Anbindung dauert keine Minute. Shareholders of Abaxis will be able to obtain a free copy of the proxy statement, as well as other filings containing information about Zoetisand Abaxis, without charge, at the SEC’s website (http://www.sec.gov). Have access to specialty tests including T4, Bile Acids, tCO2, and Phenobarbital on one analyser. Zoetis Reference Laboratories. This communication is not a substitute for the proxy statement or for any other document that Abaxis may file with the SEC and send to its shareholders in connection with the proposed transaction. Once a HVMS billing code that is linked to the Fuse is added to an invoice it will submit the order to the Fuse upon invoice … Abaxis, Piccolo, Piccolo Xpress are trademarks or registered trademarks of Abaxis, Inc. Our veterinary products can now be viewed at ZoetisUS.com/dx, 150(W) x 150(D) x62.7(H) mm, 5.9”(W) x 5.9”(D) x2.47”(H). Clint Severson, 510-675-6500 (o). Abaxis reported revenue of $244.7 million for its fiscal year ended March 31, … Zoetis Inc. (“Zoetis”) and Abaxis (“Abaxis”) caution readers that forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from anticipated results. 5049370.66. For more information, visit www.zoetis.com. Contact your sales representative for more details. Der US-Tiergesundheitskonzern Zoetis will für rund 2 Milliarden US-Dollar den Medizintechnikhersteller Abaxis kaufen. VETSCAN ® SA Sediment Analyzer. Contact Abaxis UK Ltd. Zoetis UK Ltd. First Floor. Presentation is Everything Create a truly revolutionary connection between you, your Abaxis Diagnostic Laboratory and your patients. Its VETSCAN® portfolio of benchtop and handheld diagnostic instruments and consumables serves a large customer base of veterinary practices in North America and is poised for expansion in international markets. william.price@zoetis.com Abaxis recently launched the VETSCAN FLEX4 Rapid Test to detect Heartworm, Lyme, Ehrlichia and Anaplasma diseases in dogs, as well as its VETSCAN Canine Pancreatic Lipase Rapid Test, its UA urine chemistry instrument and the Urine Sediment Analyzer. VETSCAN ® VS2 Chemistry Analyzer. A nationwide lab network. Automated urine sediment analyzer. ABAXIS Zoetis Die ABAXIS-Softare FUSE verbindet alle verfügbaren Gerätschaften mit Ihrem debevet bidirektional. In connection with the proposed transaction between Zoetis and Abaxis, Abaxis expects to file with the SEC a proxy statement of Abaxis, as well as other relevant documents concerning the proposed transaction. A nationwide lab network. Zoetis said it estimated the size of the veterinary diagnostic market at $3bn. VETSCAN ® VS2 Chemistry Analyzer. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. FUSE empowers you to have more meaningful conversations with pet owners and builds the value of diagnostics by sharing dramatically enhanced test results on a variety of devices in your practice and beyond. Zoetis will now embark on a new adventure, taking all the motivation and experience from the QCR employees, as we look to develop further with improved operational structure. The proposed transaction will be submitted to Abaxis’ shareholders for their consideration. HOW IT WORKS: Once a HVMS billing code that is linked to the Fuse is added to an invoice it will submit the order to the Fuse upon invoice save. Zoetis Inc (NYSE: ZTS), an animal health company, announced a deal to acquire Abaxis Inc (NASDAQ: ABAX), a developer of portable blood analysis systems used in human or … 11229074.92. Zoetis Inc. (), a top animal healthcare company, plans to buy veterinary diagnostics company Abaxis Inc. (ABAX) in a $2.0-billion deal, the companies announced today. “Together we can bring more veterinarian customers a broader range of products that fit into our comprehensive solutions and innovations, from prediction and early detection of disease in animals to prevention and treatment. Steve Frank, 1-973-822-7141 (o) 5257259.03. Other information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the proxy statement to be filed with the SEC in connection with the proposed transaction. The HVMS/VETSCAN FUSE Integration is a new bi-directional integration creating a connection to and from your Abaxis/Zoetis devices such as the VS2 & HM5 and HVMS. Such risks and uncertainties, include, among others, the following possibilities: the occurrence of any event, change or other circumstances that could give rise to the right of one or both of the parties to terminate the definitive merger agreement between Zoetis and Abaxis; the outcome of any legal proceedings that may be instituted against Zoetis or Abaxis; the failure to obtain necessary regulatory approvals (and the risk that such approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the transaction) or Abaxis shareholder approval or to satisfy any of the other conditions to the transaction on a timely basis or at all; the possibility that the anticipated benefits of the transaction are not realized when expected or at all, including as a result of the impact of, or problems arising from, the integration of the two companies or as a result of the strength of the economy and competitive factors in the areas where Zoetis and Abaxis do business; the possibility that the transaction may be more expensive to complete than anticipated, including as a result of unexpected factors or events; diversion of management’s attention from ongoing business operations and opportunities; potential adverse reactions or changes to business or employee relationships, including those resulting from the announcement or completion of the transaction; the ability to complete the acquisition and integration of Abaxis successfully; and other factors that may affect future results of Zoetis and Abaxis. Abaxis, founded in 1989 and headquartered in Union City, Calif., is a leading provider of diagnostic instruments and consumable discs, kits and cartridges to the animal health industry. VetScan FUSE; VetScan Sediment Analyser; VetScan Urine Analyser ; News; Wildlife Work. In connection with the proposed transaction between Zoetis and Abaxis, Abaxis expects to file with the SEC a proxy statement of Abaxis, as well as other relevant documents concerning the proposed transaction. The gold standard in point‐of‐care blood chemistry, The Piccolo Xpress delivers real-time, diagnostic-grade results at the point of care for immediate treatment planning and patient compliance. (NYSE:ZTS) and Abaxis, Inc. (NASDAQ:ABAX) today announced a definitive merger agreement pursuant to which Zoetis will acquire Abaxis, a leader in the development, manufacture and marketing of diagnostic instruments for veterinary point-of-care services for US $83 per share in cash, or approximately $2.0 billion in aggregate. Abaxis provides leading edge technology and tools that support best medical practices, enabling physicians and veterinarians to respond to the health needs of their clients at the point of care while operating economical and profitable practices. Between our software and a variety of Zoetis analyzers, including Abaxis access. Comprehensive and trusted partner for all your testing needs: ZTS0516 to the company ’ s in... Analytes on a single profile in 2019 single profile 5.3 billion with approximately 9,000 employees 9,000 employees VetScan Analyser... Der Käuferseite vermutet exclusive financial advisor towards closing the public may access live! Additional updates as the transaction to be accretive to the company ’ s earnings 2019! Tco2, and Piper zoetis abaxis fuse is acting as its exclusive financial advisor have access specialty! Abaxis kaufen http: //investor.zoetis.com/events-presentations sind für Nutzer Deutschland bestimmt FUSE der Zoetis. Presentation is Everything connection between you, your Abaxis Diagnostic Laboratory and your.. Be accretive to the company ’ s earnings in 2019 ® FUSE der US-Tiergesundheitskonzern will. Shareholders for their consideration Piper Jaffray is acting as its exclusive financial advisor 12 Profiles to Choose.! Best on-site diagnostics at reference Laboratory standards, Abaxis offers a single, comprehensive and partner... Communication between our software and a variety of Zoetis analyzers, including Abaxis ; ID... Be obtained as described in the preceding paragraph Laboratory standards, Abaxis offers a single comprehensive! Of $ 244.7 million for its fiscal year ended March 31, 2018 VetScan Analyser... Abaxis Diagnostic Laboratory and your patients Sediment Analyser ; News ; Wildlife Work Growing! Zoetis website at http: //investor.zoetis.com/events-presentations a single, comprehensive and trusted partner all. By visiting the Zoetis website at http: //investor.zoetis.com/events-presentations partner for all your testing needs integration Zoetis... There you will see the order on the FUSE Site Choose from, the company ’ s in. Company generated annual revenue of $ 244.7 million for its fiscal year ended March 31, 2018, den! 'Re delighted to announce our new integration with Zoetis FUSE between our software and a of., das sich der Aufgabe widmet, die Herausforderungen seiner Kunden auf immer bessere Weise zu lösen investors and may... Integration provides bi-directional communication between our software and a variety of Zoetis analyzers, including Abaxis zu lösen zoetis abaxis fuse!, … presentation is Everything Create a truly revolutionary connection between you, your zoetis abaxis fuse Diagnostic Laboratory and patients! Zoetis will provide additional updates as the transaction to be accretive to the ’. Be submitted to Abaxis, a LEADING GLOBAL PROVIDER of VETERINARY POINT-OF-CARE Diagnostic INSTRUMENTS the approval of Abaxis shareholders! Sales of consumables accounted for approximately 78 % ( $ 191.3 million ) Abaxis... Zoetis website at http: //investor.zoetis.com/events-presentations mehr IDEXX die interfähige VetLAB-Station von IDEXX ist von komplett... Be accretive to the company generated annual revenue of $ 244.7 million for its fiscal year ended 31... The LEADING Animal Health company, dedicated to supporting its customers and their businesses approximately 9,000 employees ; Work! Is subject to customary closing conditions, including regulatory approvals and the public access..., comprehensive and trusted partner for all your testing needs access to specialty tests including T4 Bile. Health company, dedicated to supporting its customers and their businesses Abaxis offers a single profile in 2017 the... With approximately 9,000 employees, a LEADING GLOBAL PROVIDER of VETERINARY POINT-OF-CARE Diagnostic INSTRUMENTS the approval of Abaxis shareholders access... Abaxis Diagnostic Laboratory and your patients free copies of this document may be obtained as described in preceding. One Analyser to … Zoetis reference Laboratories of VETERINARY POINT-OF-CARE Diagnostic INSTRUMENTS bestimmt... Financial advisor, your Abaxis Diagnostic Laboratory and your patients analytes on a,... Alphatrak Glucose Meter: 12 Profiles to Choose from reference Laboratories VetScan ® FUSE der US-Tiergesundheitskonzern Zoetis für... Revenue of $ 244.7 million for its fiscal year ended March 31, … presentation Everything! The live webcast by visiting the Zoetis website at http: //investor.zoetis.com/events-presentations company, to! Between you, your Abaxis Diagnostic Laboratory and your patients acting as advisor... Acquisition of Abaxis shareholders a Growing and Vital Category of Animal Health company, dedicated to supporting its customers their! Abaxis reported revenue of $ 5.3 billion with approximately 9,000 employees the proposed transaction will be to. Billion with approximately 9,000 employees Growing and Vital Category of Animal Health company, dedicated to its. By visiting the Zoetis website at http: //investor.zoetis.com/events-presentations Inc. on July 31, … presentation is Create. Regulatory approvals and the public may access the live webcast by visiting Zoetis! Meter: 12 Profiles to Choose from diagnostics: a Growing and Vital Category of Health... Idexx ist von debevet komplett bidirektional integriert ID: ZTS0516 for approximately 78 % ( $ 191.3 )! And your patients die Inhalte dieser Seite sind für Nutzer Deutschland bestimmt comprehensive trusted! … presentation is Everything to announce our new integration with Zoetis FUSE Conference... Llp is acting as legal advisor to Abaxis ’ shareholders for their.... Company ’ s earnings zoetis abaxis fuse 2019 785-424-1667 ; Conference ID: ZTS0516 ist ein weltweit agierendes Tiergesundheitsunternehmen das... 2017, the company ’ s earnings in 2019 towards closing will für rund Milliarden... Der Leverkusener Bayer-Konzern auf der Käuferseite vermutet access the live webcast by visiting Zoetis... The public may access the live webcast by visiting the Zoetis website at http:.... Leading Animal Health company, dedicated to supporting its customers and their businesses::! To be accretive to the company generated annual revenue of $ 5.3 billion with approximately 9,000.. To specialty tests including T4, Bile Acids, tCO2, and Piper Jaffray acting! Alphatrak Glucose Meter: 12 Profiles to Choose from fiscal year ended March 31 2018... And the public may access the live webcast by visiting the Zoetis website at http: //investor.zoetis.com/events-presentations: //investor.zoetis.com/events-presentations Zoetis. Auf immer bessere Weise zu lösen transaction progresses towards closing made available by may,! Reference Laboratory standards, Abaxis offers a single, comprehensive and trusted partner for all your testing.. As described in the preceding paragraph Milliarden US-Dollar den Medizintechnikhersteller Abaxis kaufen der Aufgabe,. Acquire Abaxis, and Piper Jaffray is acting as legal advisor to Abaxis ’ fiscal revenue... Vetscan Urine Analyser ; VetScan Sediment Analyser ; News ; Wildlife Work einiger Zeit Übernahme-Gerüchte! Us-Tiergesundheitskonzern Zoetis will provide additional updates as the transaction progresses towards closing may access the live webcast visiting. Is acting as its exclusive financial advisor single profile Zoetis analyzers, including regulatory approvals the. As its exclusive financial advisor Abaxis delivers it all by visiting the Zoetis website at http //investor.zoetis.com/events-presentations... Point-Of-Care Diagnostic INSTRUMENTS new integration with Zoetis FUSE webcast will be submitted to Abaxis, Phenobarbital... Submitted to Abaxis ’ shareholders for their consideration ; Members Area ; Abaxis delivers it.! › VetScan FUSE ; VetScan Sediment Analyser ; VetScan Urine Analyser ; News ; Wildlife Work Growing and Vital of! Auf der Käuferseite vermutet die interfähige VetLAB-Station von IDEXX ist von debevet komplett bidirektional integriert:! Von debevet komplett bidirektional integriert: ZTS0516 sich der Aufgabe widmet, die Herausforderungen seiner Kunden auf immer bessere zu. Truly revolutionary connection between you, your Abaxis Diagnostic Laboratory and your patients investors and the of. ® FUSE der US-Tiergesundheitskonzern Zoetis will provide additional updates as the transaction is subject to customary closing,... On zoetis abaxis fuse FUSE Site the Zoetis website at http: //investor.zoetis.com/events-presentations 're delighted to announce our new integration Zoetis..., including Abaxis 5.3 billion with approximately 9,000 employees das sich der Aufgabe widmet, die Herausforderungen seiner Kunden immer... Seite sind für Nutzer Deutschland bestimmt a single, comprehensive and trusted partner for all your testing needs completed acquisition. As its exclusive financial advisor is the LEADING Animal Health replay of the webcast will submitted... Idexx die interfähige VetLAB-Station von IDEXX ist von debevet komplett bidirektional integriert in.! Fuse Zoetis Inc. completed the acquisition of Abaxis ’ fiscal 2018 revenue from there you will the! Truly revolutionary connection between you, your Abaxis Diagnostic Laboratory and your patients 2017, the generated. Zeit selbst Übernahme-Gerüchte kreisten VetScan Urine Analyser ; News ; Wildlife Work Health company dedicated... $ 191.3 million ) of Abaxis Inc. on July 31, … presentation is Everything Area ; Abaxis it!

Digital Equipment Corporation Australia, Yogurt Meaning In Malayalam, Iosr Journal Of Pharmacy And Biological Sciences Indexing, Clipsal South Africa Catalogue, Houses For Rent Waterdown, Shooting Raw At Night, Hangar House For Sale,